24 May 2013
Keywords: sanofi, ucb, enter, co-promotion, deal, xyzal, french
Article | 02 October 2006
French drug major Sanofi-Aventis and Belgium's UCB have entered into an agreement to co-promote Xyzal (levocetirizine dihydrochloride) in the
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
2 October 2006
23 May 2013
© 2013 thepharmaletter.com